Parent Interventions: GI symptoms linked to behavioral problems in children  |  Parent Interventions: Research Finds Women Often Overprescribed Opioids After Childbirth  |  Parent Interventions: Human milk based fortifiers improve health outcomes for premature babies  |  National Edu News: Capturing the voice of the unreached in S&T policy formulation  |  Leadership Instincts: British and Indian experts join forces to battle 'superbugs'   |  Parent Interventions: Coronavirus-related children's diseases linked to blood cell changes  |  International Edu News: Being Human Festival returns  |  International Edu News: Warwick Hosts another year of the Data Science for Social Good programme   |  Science Innovations: Research captures how human sperm swim in 3D  |  International Edu News: Bristol students launch international charity scheme  |  International Edu News: Happier people are more likely to comply with lockdown restrictions  |  Leadership Instincts: The University of Manchester launches its Innovation Factory  |  International Edu News: UCL launches new Centre on US Politics  |  Education Information: Student Entrepreneurship Programme 2.0  |  Education Information: Digital transformation opportunities emerged from COVID 19 disruptions  |  
November 22, 2019 Friday 11:03:56 AM IST

New system to control blood glucose levels

Science Innovations

A clinical trial evaluating a new artificial pancreas system - which automatically monitors and regulates blood glucose levels - has found that the new system is more effective than existing treatments at controlling blood glucose levels in people with type 1 diabetes. The trial, based partly at the University of Virginia Center for Diabetes Technology, was published in the New England Journal of Medicine.

The artificial pancreas, also known as closed-loop control, is an ‘all-in-one’ diabetes management system that tracks blood glucose levels using a continuous glucose monitor (CGM) and automatically delivers the hormone insulin when needed using an insulin pump. The system replaces reliance on testing by fingerstick or CGM with separate delivery of insulin by multiple daily injections or a pump.

The system improved blood glucose control throughout the day and overnight. Overnight control has been a challenge since blood glucose can drop to dangerously low levels when a person is asleep.


Comments